Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Brenda Doreen Griffin"'
Autor:
Robert A. Somerville, Peter R. Foster, Brenda Doreen Griffin, H E Reichl, Ian MacGregor, Phillip J. Steele, Ronald Vance Mcintosh, C. Bienek
Publikováno v:
Vox Sanguinis. 86:92-99
Background and Objectives The risk of haemophiliacs contracting variant Creutzfeldt-Jakob disease (vCJD) via treatment with factor VIII concentrates is not known. Therefore, in order to determine the extent to which the vCJD agent might be removed du
Publikováno v:
Thrombosis and Haemostasis. 57:102-105
SummaryMurine monoclonal antibodies to human von Willebrand factor (vWf) were immobilised on Sephacryl S-1000. Various solutes were screened for their ability to elute 125 I-vWf from the immobilised antibodies. The most effective solutions were then
Publikováno v:
Thrombosis and Haemostasis. 55:040-046
SummaryA panel of 10 murine monoclonal antibodies to procoagulant FVIII has been developed from the fusion of a single spleen. Balb/c mice were injected with a purified preparation of FVIII: Ag, and antibody production in sera and hybrid culture supe
Autor:
Alan J. Dickson, Ida H. Dickson, Brenda Doreen Griffin, Thomas A. McQuillan, Christopher V. Prowse, Peter R. Foster, Duncan S. Pepper
Publikováno v:
Thrombosis and Haemostasis. 46:597-601
SummarySamples taken at various stages of preparation of intermediate purity factor VIII concentrate were assayed for factor VIII coagulant activity (VIII:C), factor VIII coagulant antigen (VIIIC: Ag) and factor VIII related antigen (VIIIR: Ag). The
Publikováno v:
Thrombosis and Haemostasis. 46:543-546
SummaryThe thaw-siphon procedure for routine production of cryoprecipitate is described briefly, and also its extension to a reproducible procedure for production of cryoprecipitates of intermediate purity. For the latter, the average yield of factor
Publikováno v:
Scopus-Elsevier
SummaryEarly work on the purification of factor VIII using polyethylene glycol (PEG) indicated that other polymers might also be used to precipitate factor VIII leaving fibrinogen in solution. Recently polyvinylpyrrolidone (PVP) has also been advocat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a33b765923927d5ccf1c0f3095ba1694
http://www.scopus.com/inward/record.url?eid=2-s2.0-0021230073&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0021230073&partnerID=MN8TOARS
Publikováno v:
The Lancet. 318:449-450